ReviewCancers2017

Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas.

Coralie Hoareau-Aveilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.